Literature DB >> 30442762

Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination.

M Steklov1,2, S Pandolfi1,2, M F Baietti1,2, A Batiuk1,2, P Carai3, P Najm1,2, M Zhang4, H Jang4, F Renzi1,2, Y Cai1,2, L Abbasi Asbagh1,2, T Pastor1,2, M De Troyer1,2, M Simicek1,2, E Radaelli5, H Brems5, E Legius5, J Tavernier6,7, K Gevaert6,7, F Impens8, L Messiaen5,9, R Nussinov4,10, S Heymans3,11,12, S Eyckerman6,7, A A Sablina13,2.   

Abstract

The leucine zipper-like transcriptional regulator 1 (LZTR1) protein, an adaptor for cullin 3 (CUL3) ubiquitin ligase complex, is implicated in human disease, yet its mechanism of action remains unknown. We found that Lztr1 haploinsufficiency in mice recapitulates Noonan syndrome phenotypes, whereas LZTR1 loss in Schwann cells drives dedifferentiation and proliferation. By trapping LZTR1 complexes from intact mammalian cells, we identified the guanosine triphosphatase RAS as a substrate for the LZTR1-CUL3 complex. Ubiquitome analysis showed that loss of Lztr1 abrogated Ras ubiquitination at lysine-170. LZTR1-mediated ubiquitination inhibited RAS signaling by attenuating its association with the membrane. Disease-associated LZTR1 mutations disrupted either LZTR1-CUL3 complex formation or its interaction with RAS proteins. RAS regulation by LZTR1-mediated ubiquitination provides an explanation for the role of LZTR1 in human disease.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30442762      PMCID: PMC8058620          DOI: 10.1126/science.aap7607

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.

Authors:  Guilherme Lopes Yamamoto; Meire Aguena; Monika Gos; Christina Hung; Jacek Pilch; Somayyeh Fahiminiya; Anna Abramowicz; Ingrid Cristian; Michelle Buscarilli; Michel Satya Naslavsky; Alexsandra C Malaquias; Mayana Zatz; Olaf Bodamer; Jacek Majewski; Alexander A L Jorge; Alexandre C Pereira; Chong Ae Kim; Maria Rita Passos-Bueno; Débora Romeo Bertola
Journal:  J Med Genet       Date:  2015-03-20       Impact factor: 6.318

2.  Rabex-5 ubiquitin ligase activity restricts Ras signaling to establish pathway homeostasis in Drosophila.

Authors:  Hua Yan; Maryam Jahanshahi; Elizabeth A Horvath; Hsiu-Yu Liu; Cathie M Pfleger
Journal:  Curr Biol       Date:  2010-07-22       Impact factor: 10.834

3.  Feedback regulation of Ras signaling by Rabex-5-mediated ubiquitination.

Authors:  Lizhong Xu; Veronica Lubkov; Laura J Taylor; Dafna Bar-Sagi
Journal:  Curr Biol       Date:  2010-07-22       Impact factor: 10.834

4.  Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.

Authors:  Arkadiusz Piotrowski; Jing Xie; Ying F Liu; Andrzej B Poplawski; Alicia R Gomes; Piotr Madanecki; Chuanhua Fu; Michael R Crowley; David K Crossman; Linlea Armstrong; Dusica Babovic-Vuksanovic; Amanda Bergner; Jaishri O Blakeley; Andrea L Blumenthal; Molly S Daniels; Howard Feit; Kathy Gardner; Stephanie Hurst; Christine Kobelka; Chung Lee; Rebecca Nagy; Katherine A Rauen; John M Slopis; Pim Suwannarat; Judith A Westman; Andrea Zanko; Bruce R Korf; Ludwine M Messiaen
Journal:  Nat Genet       Date:  2013-12-22       Impact factor: 38.330

5.  Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis.

Authors:  Taoling Zeng; Qun Wang; Jieying Fu; Qi Lin; Jing Bi; Weichao Ding; Yikai Qiao; Sheng Zhang; Wenxiu Zhao; Huayue Lin; Meilin Wang; Binfeng Lu; Xianming Deng; Dawang Zhou; Zhenyu Yin; Hong-Rui Wang
Journal:  Cell Rep       Date:  2014-04-17       Impact factor: 9.423

Review 6.  When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling.

Authors:  Lan K Nguyen; Walter Kolch; Boris N Kholodenko
Journal:  Cell Commun Signal       Date:  2013-07-31       Impact factor: 5.712

7.  Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.

Authors: 
Journal:  Cell       Date:  2017-06-15       Impact factor: 66.850

8.  Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.

Authors:  Zhongqi Ge; Jake S Leighton; Yumeng Wang; Xinxin Peng; Zhongyuan Chen; Hu Chen; Yutong Sun; Fan Yao; Jun Li; Huiwen Zhang; Jianfang Liu; Craig D Shriver; Hai Hu; Helen Piwnica-Worms; Li Ma; Han Liang
Journal:  Cell Rep       Date:  2018-04-03       Impact factor: 9.995

9.  Trapping mammalian protein complexes in viral particles.

Authors:  Sven Eyckerman; Kevin Titeca; Emmy Van Quickelberghe; Eva Cloots; Annick Verhee; Noortje Samyn; Leentje De Ceuninck; Evy Timmerman; Delphine De Sutter; Sam Lievens; Serge Van Calenbergh; Kris Gevaert; Jan Tavernier
Journal:  Nat Commun       Date:  2016-04-28       Impact factor: 14.919

10.  Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.

Authors:  Melissa R Marzahn; Suresh Marada; Jihun Lee; Amanda Nourse; Sophia Kenrick; Huaying Zhao; Gili Ben-Nissan; Regina-Maria Kolaitis; Jennifer L Peters; Stanley Pounds; Wesley J Errington; Gilbert G Privé; J Paul Taylor; Michal Sharon; Peter Schuck; Stacey K Ogden; Tanja Mittag
Journal:  EMBO J       Date:  2016-05-23       Impact factor: 11.598

View more
  64 in total

1.  Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.

Authors:  Yline Capri; Elisabetta Flex; Oliver H F Krumbach; Giovanna Carpentieri; Serena Cecchetti; Christina Lißewski; Soheila Rezaei Adariani; Denny Schanze; Julia Brinkmann; Juliette Piard; Francesca Pantaleoni; Francesca R Lepri; Elaine Suk-Ying Goh; Karen Chong; Elliot Stieglitz; Julia Meyer; Alma Kuechler; Nuria C Bramswig; Stephanie Sacharow; Marion Strullu; Yoann Vial; Cédric Vignal; George Kensah; Goran Cuturilo; Neda S Kazemein Jasemi; Radovan Dvorsky; Kristin G Monaghan; Lisa M Vincent; Hélène Cavé; Alain Verloes; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

2.  Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.

Authors:  Eric Legius; Hilde Brems
Journal:  Childs Nerv Syst       Date:  2020-06-29       Impact factor: 1.475

Review 3.  Inhibition of Nonfunctional Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Attila Gursoy; Ozlem Keskin; Vadim Gaponenko
Journal:  Cell Chem Biol       Date:  2021-01-12       Impact factor: 8.116

Review 4.  Biology, pathology, and therapeutic targeting of RAS.

Authors:  J Matthew Rhett; Imran Khan; John P O'Bryan
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

Review 5.  Regulation of large and small G proteins by ubiquitination.

Authors:  Henrik G Dohlman; Sharon L Campbell
Journal:  J Biol Chem       Date:  2019-10-23       Impact factor: 5.157

Review 6.  Swimming toward solutions: Using fish and frogs as models for understanding RASopathies.

Authors:  Victoria L Patterson; Rebecca D Burdine
Journal:  Birth Defects Res       Date:  2020-06-07       Impact factor: 2.344

Review 7.  Monitoring protein communities and their responses to therapeutics.

Authors:  Hanna G Budayeva; Donald S Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2020-03-05       Impact factor: 84.694

8.  DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis.

Authors:  Barbara Rivera; Javad Nadaf; Somayyeh Fahiminiya; Maria Apellaniz-Ruiz; Avi Saskin; Anne-Sophie Chong; Sahil Sharma; Rabea Wagener; Timothée Revil; Vincenzo Condello; Zineb Harra; Nancy Hamel; Nelly Sabbaghian; Karl Muchantef; Christian Thomas; Leanne de Kock; Marie-Noëlle Hébert-Blouin; Angelia V Bassenden; Hannah Rabenstein; Ozgur Mete; Ralf Paschke; Marc P Pusztaszeri; Werner Paulus; Albert Berghuis; Jiannis Ragoussis; Yuri E Nikiforov; Reiner Siebert; Steffen Albrecht; Robert Turcotte; Martin Hasselblatt; Marc R Fabian; William D Foulkes
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

9.  RIT1 oncoproteins escape LZTR1-mediated proteolysis.

Authors:  Pau Castel; Alice Cheng; Antonio Cuevas-Navarro; David B Everman; Alex G Papageorge; Dhirendra K Simanshu; Alexandra Tankka; Jacqueline Galeas; Anatoly Urisman; Frank McCormick
Journal:  Science       Date:  2019-03-15       Impact factor: 47.728

Review 10.  Therapeutic targeting of RAS: New hope for drugging the "undruggable".

Authors:  Imran Khan; J Matthew Rhett; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-10-31       Impact factor: 4.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.